Within the next 12 months these are the big ticket items that will give PTX holders their shot at financial freedom;
• Final data on the Phase 1b PTX-200 breast cancer trial
• Pre-clinical work in PTX-100 in RhoA mutant cancers
• Completion of PTX-200 AML Phase 1b trial
• Completion of PTX-200 Ovarian cancer Phase 1b trial
• Re-entering the clinic with PTX-100 in haematological malignancies
With a cash balance sufficient to operate through to 2019, it pretty much gives current holders a free shot at some short term returns. SP appears to have consolidated nicely at 7 cents, which given the recent spade of good news is heavily discounted to the 52 week average. IMO PTX is primed, this is definitely in the space of undervalued and under the radar!
PTX Price at posting:
7.0¢ Sentiment: Buy Disclosure: Held
